AMERICAN SOCIETY FOR CLINICAL PATHOLOGY

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Laboratory Oversight; Diagnostic Devices oversight; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Medicare Quality Payment Program; Medicare National and Local Coverage Determinations; Medical Devices and Oversight of Laboratory Tests; Physician and Clinical Laboratory Professionals Shortages, Education, and Loan Forgiveness for healthcare professionals; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity; Communicable Diseases and Pandemic Preparedness; Stark Self-Referral Reform

Medicare; Electronic Health Records/Health Information Technology; Medicare Access and CHIP Reauthorization Act; Protecting Access to Medicare Act; Medicare Physician and Clinical Laboratory Fee Schedules; Stark Self-Referral Reform; Physician and Clinical Laboratory Professionals Shortages/workforce issues, Education, and Loan Forgiveness Funding; Appropriations for Federal Agencies; Global Health Initiative, Laboratory Access for Beneficiaries (LAB) Act, Clinical Laboratory Improvement Amendments; Issues Related to COVID-19 Response and Laboratory Testing Capacity; Communicable Diseases and Pandemic Preparedness, and oversight of laboratory test development.

Physician, Clinical Laboratory Professional, and Allied Workforce Issues, Federal Funding for Education, Student Loan Repayment/Forgiveness, and Related Workforce Development; Workforce Reinvestment Act; Federal Healthcare Workforce Issues; Appropriations for Federal Agencies; Clinical Laboratory Improvement Amendments; COVID-19 Response and Laboratory Test Capacity.